70,002 Shares in Ultralife Co. (NASDAQ:ULBI) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. purchased a new stake in Ultralife Co. (NASDAQ:ULBI - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 70,002 shares of the technology company's stock, valued at approximately $522,000. Raymond James Financial Inc. owned 0.42% of Ultralife as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. IFP Advisors Inc acquired a new stake in shares of Ultralife in the fourth quarter valued at $85,000. Barclays PLC boosted its stake in shares of Ultralife by 21.3% in the 3rd quarter. Barclays PLC now owns 13,395 shares of the technology company's stock valued at $121,000 after buying an additional 2,355 shares during the period. Jane Street Group LLC acquired a new position in shares of Ultralife during the third quarter worth about $166,000. Bank of New York Mellon Corp increased its stake in shares of Ultralife by 35.7% during the fourth quarter. Bank of New York Mellon Corp now owns 43,541 shares of the technology company's stock worth $324,000 after buying an additional 11,448 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in Ultralife by 250.8% in the third quarter. JPMorgan Chase & Co. now owns 47,458 shares of the technology company's stock valued at $429,000 after acquiring an additional 33,929 shares in the last quarter. Hedge funds and other institutional investors own 30.68% of the company's stock.

Ultralife Stock Up 1.5 %

NASDAQ ULBI traded up $0.07 during trading on Friday, reaching $4.72. 60,955 shares of the company's stock were exchanged, compared to its average volume of 75,987. The company has a 50 day moving average price of $5.92 and a two-hundred day moving average price of $7.34. The stock has a market cap of $78.51 million, a P/E ratio of 8.58 and a beta of 0.96. Ultralife Co. has a 1 year low of $4.20 and a 1 year high of $13.39. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.62 and a current ratio of 3.30.

Ultralife (NASDAQ:ULBI - Get Free Report) last posted its earnings results on Tuesday, April 1st. The technology company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.14). The business had revenue of $43.85 million for the quarter, compared to analysts' expectations of $40.00 million. Ultralife had a return on equity of 7.92% and a net margin of 5.44%. During the same quarter in the previous year, the firm earned $0.18 EPS.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Ultralife from a "buy" rating to a "hold" rating in a report on Tuesday, March 18th.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.